Walgreens Boots Alliance Offers Major Upside

NASDAQ: WBA | Walgreens Boots Alliance, Inc. News, Ratings, and Charts

WBA – Walgreens Boots Alliance (WBA) is attractive from a value and growth perspective. While the stock has lagged the market over the past few years, WBA has increased its market share during this time.

  • Consolidation in the industry

  • A bullish trend since November 2020

  • Recent earnings have been impressive

  • Annual revenues are growing

  • A juicy dividend and much higher targets on the long-term chart

Walgreens Boots Alliance, Inc. (WBA) operates a pharmacy-lead health and beauty retail company. WBA operates through three segments including, Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.

As of the end of August 2020, the Retail US segment operated 9,021 retail stores under the Walgreens and Duane Reed brands and six specialty pharmacies. The international segment operated 4,428 retail stores under the Boots, Benavides, and Ahumada brands in the United Kingdom, Thailand, Norway, Ireland, the Netherlands, Mexico, Chile, and 550 optical practices; 165 operate on a franchise basis. The Wholesale segment engages in wholesale distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, and related services to pharmacies and healthcare providers. The segment operates in countries worldwide, even in locations where WBA does not have retail stores.

WBA has been in business since 1901, with its headquarters in Deerfield, Illinois.

The company had a $47.075 billion market cap at $54.53 per share as of May 7 and has tremendous growth potential.

Consolidation in the industry

In the US, Walgreens Boots Alliance (WBA) and CVS Health Corporation (CVS) are the two dominant forces in the pharmacy-led health and beauty retail sector. The global pandemic spotlighted these companies, as their retail outlets reach the overwhelming share of the addressable market, a combined nearly 19,000 locations across the United States. While the two companies have almost the same number of sites, WBA’s portfolio includes thousands more worldwide.

WBA and CVS have a lock on the growth industry. The pandemic has only increased their profiles as both are convenient locations for the COVID-19 vaccines.

A bullish trend since November 2020

After reaching a low of $33.36 on October 30, 2020, WBA shares have made higher lows and higher highs.

Source: Barchart

As the chart highlights, WBA rose to its latest peak at $57.05 on April 6, 2021 and was trading not far below that level on May 7 at around the $54.53 level.

Meanwhile, WBA shares could have lots of upside room as they are nowhere near the all-time high.

Source: Barchart

The long-term chart dating back to the 1980s illustrates WBA reached its record high in August 2015 at $97.30 per share, nearly 80% above the current price level.

Recent earnings have been impressive

Since Q2 2020, WBA beat consensus EPS forecasts half of the time. Over the past two quarters, the company exceeded expectations.

Source: Yahoo Finance

As the chart shows, the most recent earnings report for Q1 2021 came in at $1.26 per share versus consensus forecasts for $1.11. The earnings trend over the past three quarters has been positive.

Annual revenues are growing

WBA’s revenues have also been rising consistently over the past years.

Source: Yahoo Finance

The chart shows the growth trend from 2017 through 2020.

Source: Yahoo Finance

The quarterly trend was uneven in 2020 as the pandemic weighed on all retail businesses. However, the higher level in Q1 2021 compared to Q4 2020 is a positive sign. A survey of eighteen analysts on Yahoo Finance has an average price target of $54.22 per share for WBA, with forecasts ranging from $33 to $72. While the stock is trading right near the average, analysts continue to view the prospects in a mostly positive light.

Source: Yahoo Finance

As the chart shows, the current ratings are all neutral to outperform for the stock.

A juicy dividend and much higher targets on the long-term chart

One of the most attractive factors for WBA is the company’s dividend yield. The $1.87 per share dividend translates to a 3.43% yield at $54.32, higher than CVS’s 2.35% yield at $85.11 per share.

Source: Yahoo Finance

The first upside technical target for WBA shares is at the November 2019 $64.50 high. Above there, the December 2018 $86.31 peak and the August 2015 $97.30 high are targets for the bulls.

Given its position in the sector and its global footprint, WBA is a growth stock that pays investors a handsome dividend while they wait for capital appreciation.


WBA shares were trading at $54.60 per share on Tuesday morning, down $0.51 (-0.93%). Year-to-date, WBA has gained 38.22%, versus a 10.86% rise in the benchmark S&P 500 index during the same period.


About the Author: Andrew Hecht


Andy spent nearly 35 years on Wall Street and is a sought-after commodity and futures trader, an options expert and analyst. In addition to working with StockNews, he is a top ranked author on Seeking Alpha. Learn more about Andy’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
WBAGet RatingGet RatingGet Rating
CVSGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Is the Bear Market Here?

We are witnessing the nastiest stock market (SPY) correction since Covid first came on the scene. That has some pondering if the next bear market is upon us. 40 year veteran investor Steve Reitmeister gives his clear eyed view on the market outlook and trading plan in this timely commentary. Get the full story below...

:  |  News, Ratings, and Charts

3 Stocks that Are Thriving in an Inflationary Environment

Inflation is one of the biggest threats facing the economy. One profitable strategy during this period of high inflation is to focus on stocks that have pricing power, as these companies’ margins will continue to expand. In contrast, stocks without pricing power are likely to underperform as margin compression erodes EPS. Therefore, investors should consider buying these 3 stocks that are thriving in this inflationary environment: Olin (OLN), Nucor (NUE), and Chemours (CC).

:  |  News, Ratings, and Charts

3 Reasons to LOVE Stocks Under $10

The stock market can be a brutal place. Far too often, today’s winners will turn into tomorrow’s losers. Just think of all the excitement generated by stocks like Peleton, Zoom, and Teladoc. These stocks soared higher in 2020 and the early parts of 2021 only to crumble in recent months, punishing those who were greedy and overstayed their welcome. But, the opposite is also true. Read on below to find out more...

:  |  News, Ratings, and Charts

4 Best Value Stocks to Buy in January

In times of high inflation, value stocks tend to outperform growth stocks and have done so over the past year. Amid the rising inflationary pressure and looming interest rate hikes, fundamentally sound value stocks ArcelorMittal (MT), Covestro (COVTY), KT Corporation (KT), and Nature’s Sunshine (NATR) could be solid bets.

:  |  News, Ratings, and Charts

3 Reasons to LOVE Stocks Under $10

The stock market can be a brutal place. Far too often, today’s winners will turn into tomorrow’s losers. Just think of all the excitement generated by stocks like Peleton, Zoom, and Teladoc. These stocks soared higher in 2020 and the early parts of 2021 only to crumble in recent months, punishing those who were greedy and overstayed their welcome. But, the opposite is also true. Read on below to find out more...

Read More Stories

More Walgreens Boots Alliance, Inc. (WBA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All WBA News